What is the difference between cell and gene therapy?

In gene therapy, genetic material is transferred, frequently in the form of a vector or carrier, and the gene is absorbed into the appropriate bodily cells. Cells that are suitable for the patients purpose are infused during cell therapy.

What is cell therapy used to treat?

Numerous illnesses, including cancer, autoimmune disorders, infections, urinary tract problems, and spinal cord injuries, may be cured using cell therapy. They could also help patients with neurological conditions and repair cartilage that has been damaged in joints.

How many cells are needed for cell therapy?

The dose ranges from 3 × 106 to 3 × 107 cells/kg. Administered in escalating doses, starting at 106 cells and working up to target levels of 109 or 1010 cells.

What are the references?

FDA, WHO, National Cancer Institute, National Health Institutes, USAID, Department of Biotechnology, Government of Canada.

Cell Therapy Market Size, Shares

Content

Executive Summary Introduction Market Segmentation Cross-Segmentation Analysis Go-to-Market Strategies Integration of AI in the Cell Therapy Market Production and Consumption Data Opportunity Assessment New Product Development Plan Finances/ROI Analysis Supply Chain Intelligence/Streamline Operations Cross Border Intelligence Business Model Innovation Blue Ocean vs. Red Ocean Strategies Competitive Landscape Company Profiles Market Trends and Insights Market Forecast Conclusion Appendices

Executive Summary

Market Overview
Key Findings
Market Trends
Market Forecast
Recommendations

Introduction

Definition of Cell Therapy
Market Dynamics
- Drivers
- Restraints
- Opportunities
- Challenges
Key Market Segments

Market Segmentation

By Therapy Type
- Autologous Therapies
  - Stem Cell Therapies
    - BM, Blood, & Umbilical Cord-derived Stem Cells
    - Adipose-Derived Cells
    - Others
  - Non-Stem Cell Therapies
    - T-Cell Therapies
      - CAR T Cell Therapy
      - T Cell Receptor (TCR)-based
      - Others
- Allogeneic Therapies
  - Stem Cell Therapies
    - Hematopoietic Stem Cell Therapies
    - Mesenchymal Stem Cell Therapies
  - Non-Stem Cell Therapies
    - Keratinocytes & Fibroblast-based Therapies
    - Others
By Therapeutic Area
- Oncology
- Musculoskeletal Disorders
- Cardiovascular Disease (CVD)
- Dermatology
- Others
By Region
- North America
  - U.S.
  - Canada
- Asia Pacific
  - China
  - Japan
  - India
  - South Korea
  - Thailand
- Europe
  - Germany
  - UK
  - France
  - Italy
  - Spain
  - Sweden
  - Denmark
  - Norway
- Latin America
  - Brazil
  - Mexico
  - Argentina
- Middle East and Africa (MEA)
  - South Africa
  - UAE
  - Saudi Arabia
  - Kuwait

Cross-Segmentation Analysis

By Therapy Type and Therapeutic Area

Autologous Therapies
- Stem Cell Therapies
  - BM, Blood, & Umbilical Cord-derived Stem Cells
    - Oncology
    - Musculoskeletal Disorders
    - Cardiovascular Disease (CVD)
    - Dermatology
    - Others
  - Adipose-Derived Cells
    - Oncology
    - Musculoskeletal Disorders
    - Cardiovascular Disease (CVD)
    - Dermatology
    - Others
  - Others
    - Oncology
    - Musculoskeletal Disorders
    - Cardiovascular Disease (CVD)
    - Dermatology
    - Others
- Non-Stem Cell Therapies
  - T-Cell Therapies
    - CAR T Cell Therapy
      - Oncology
      - Musculoskeletal Disorders
      - Cardiovascular Disease (CVD)
      - Dermatology
      - Others
    - T Cell Receptor (TCR)-based
      - Oncology
      - Musculoskeletal Disorders
      - Cardiovascular Disease (CVD)
      - Dermatology
      - Others
    - Others
      - Oncology
      - Musculoskeletal Disorders
      - Cardiovascular Disease (CVD)
      - Dermatology
      - Others
Allogeneic Therapies
- Stem Cell Therapies
  - Hematopoietic Stem Cell Therapies
    - Oncology
    - Musculoskeletal Disorders
    - Cardiovascular Disease (CVD)
    - Dermatology
    - Others
  - Mesenchymal Stem Cell Therapies
    - Oncology
    - Musculoskeletal Disorders
    - Cardiovascular Disease (CVD)
    - Dermatology
    - Others
- Non-Stem Cell Therapies
  - Keratinocytes & Fibroblast-based Therapies
    - Oncology
    - Musculoskeletal Disorders
    - Cardiovascular Disease (CVD)
    - Dermatology
    - Others
  - Others
    - Oncology
    - Musculoskeletal Disorders
    - Cardiovascular Disease (CVD)
    - Dermatology
    - Others

By Therapy Type and Region

Autologous Therapies
- Stem Cell Therapies
  - BM, Blood, & Umbilical Cord-derived Stem Cells
    - North America
      - U.S.
      - Canada
    - Asia Pacific
      - China
      - Japan
      - India
      - South Korea
      - Thailand
    - Europe
      - Germany
      - UK
      - France
      - Italy
      - Spain
      - Sweden
      - Denmark
      - Norway
    - Latin America
      - Brazil
      - Mexico
      - Argentina
    - Middle East and Africa (MEA)
      - South Africa
      - UAE
      - Saudi Arabia
      - Kuwait
  - Adipose-Derived Cells
    - North America
    - Asia Pacific
    - Europe
    - Latin America
    - Middle East and Africa (MEA)
  - Others
    - North America
    - Asia Pacific
    - Europe
    - Latin America
    - Middle East and Africa (MEA)
- Non-Stem Cell Therapies
  - T-Cell Therapies
    - CAR T Cell Therapy
      - North America
      - Asia Pacific
      - Europe
      - Latin America
      - Middle East and Africa (MEA)
    - T Cell Receptor (TCR)-based
      - North America
      - Asia Pacific
      - Europe
      - Latin America
      - Middle East and Africa (MEA)
    - Others
      - North America
      - Asia Pacific
      - Europe
      - Latin America
      - Middle East and Africa (MEA)
Allogeneic Therapies
- Stem Cell Therapies
  - Hematopoietic Stem Cell Therapies
    - North America
    - Asia Pacific
    - Europe
    - Latin America
    - Middle East and Africa (MEA)
  - Mesenchymal Stem Cell Therapies
    - North America
    - Asia Pacific
    - Europe
    - Latin America
    - Middle East and Africa (MEA)
- Non-Stem Cell Therapies
  - Keratinocytes & Fibroblast-based Therapies
    - North America
    - Asia Pacific
    - Europe
    - Latin America
    - Middle East and Africa (MEA)
  - Others
    - North America
    - Asia Pacific
    - Europe
    - Latin America
    - Middle East and Africa (MEA)

By Therapeutic Area and Region

Oncology
- North America
  - U.S.
  - Canada
- Asia Pacific
  - China
  - Japan
  - India
  - South Korea
  - Thailand
- Europe
  - Germany
  - UK
  - France
  - Italy
  - Spain
  - Sweden
  - Denmark
  - Norway
- Latin America
  - Brazil
  - Mexico
  - Argentina
- Middle East and Africa (MEA)
  - South Africa
  - UAE
  - Saudi Arabia
  - Kuwait
Musculoskeletal Disorders
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East and Africa (MEA)
Cardiovascular Disease (CVD)
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East and Africa (MEA)
Dermatology
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East and Africa (MEA)
Others
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East and Africa (MEA)

Go-to-Market Strategies

Market Entry Strategies
- Market Penetration
- Market Development
- Product Diversification
Target Market Identification
- Segmentation Analysis
- Customer Profiling
- Market Needs Assessment
Positioning and Branding
- Value Proposition
- Brand Differentiation
- Competitive Positioning
Sales and Distribution Channels
- Direct Sales
- Partnerships and Alliances
- Distribution Networks
Pricing Strategies
- Cost-Based Pricing
- Value-Based Pricing
- Competitive Pricing
Marketing and Promotion
- Advertising and Public Relations
- Digital Marketing
- Trade Shows and Conferences
Customer Engagement and Retention
- Customer Relationship Management (CRM)
- Loyalty Programs
- Feedback and Improvement
Regulatory and Compliance Considerations
- Regulatory Requirements
- Compliance Strategies
- Risk Management
Monitoring and Evaluation
- Performance Metrics
- Market Feedback
- Strategy Adjustment

Integration of AI in the Cell Therapy Market

AI-Driven Research and Development
- Drug Discovery and Development
- Predictive Modeling for Therapy Outcomes
- Personalized Therapy Design
AI in Clinical Trials
- Patient Recruitment and Enrollment
- Trial Monitoring and Data Management
- Predictive Analytics for Trial Success
AI in Manufacturing and Production
- Process Optimization
- Quality Control and Assurance
- Automation and Robotics
AI for Patient Management
- Diagnostic Tools and Predictive Analytics
- Personalized Treatment Plans
- Remote Monitoring and Support
AI in Data Management and Analysis
- Big Data Analytics
- Integration of Multi-Omics Data
- Real-Time Data Processing
AI for Market Forecasting
- Trend Analysis
- Demand Prediction
- Competitive Intelligence
Regulatory and Ethical Considerations
- Compliance with Regulations
- Ethical Implications of AI in Therapy
- Data Privacy and Security
Future Trends and Innovations
- Emerging AI Technologies
- Integration with Other Advanced Technologies
- Long-Term Impact on Cell Therapy

Production and Consumption Data

Global Production Overview
- Production Capacity by Region
- Key Manufacturers and Production Facilities
- Trends in Production Technology
Regional Production Analysis
- North America
  - U.S.
  - Canada
- Asia Pacific
  - China
  - Japan
  - India
  - South Korea
  - Thailand
- Europe
  - Germany
  - UK
  - France
  - Italy
  - Spain
  - Sweden
  - Denmark
  - Norway
- Latin America
  - Brazil
  - Mexico
  - Argentina
- Middle East and Africa (MEA)
  - South Africa
  - UAE
  - Saudi Arabia
  - Kuwait
Consumption Overview
- Global Consumption Patterns
- Major Consumer Markets
- Trends in End-Use Applications
Regional Consumption Analysis
- North America
- Asia Pacific
- Europe
- Latin America
- Middle East and Africa (MEA)
Supply Chain and Distribution
- Supply Chain Dynamics
- Distribution Channels
- Logistics and Transportation
Market Demand and Supply Dynamics
- Demand Forecasting
- Supply Chain Constraints
- Impact of Market Trends on Production and Consumption
Key Data and Statistics
- Historical Data
- Current Data
- Future Projections

Opportunity Assessment

Market Opportunities
- Emerging Trends
- Market Gaps and Needs
- Growth Potential by Segment
Competitive Opportunities
- Competitor Analysis
- Strategic Advantages
- Collaboration and Partnership Opportunities
Risk Assessment
- Market Risks
- Operational Risks
- Financial Risks

New Product Development

Idea Generation and Screening
- Market Research and Needs Analysis
- Concept Development and Testing
Product Design and Development
- Prototyping and Iteration
- Development Phases and Timelines
Market Introduction
- Launch Strategy
- Marketing and Promotion
- Post-Launch Evaluation

Plan Finances/ROI Analysis

Financial Planning
- Budgeting and Forecasting
- Capital Investment Requirements
ROI Analysis
- Return on Investment Metrics
- Cost-Benefit Analysis
- Financial Performance Evaluation
Funding and Investment
- Sources of Funding
- Investment Strategies

Supply Chain Intelligence/Streamline Operations

Supply Chain Analysis
- Supplier and Vendor Management
- Procurement Strategies
Operational Efficiency
- Process Optimization
- Technology Integration
Logistics and Distribution
- Distribution Network Management
- Inventory Control and Management

Cross Border Intelligence

Global Market Analysis
- Market Entry Strategies
- Regulatory and Compliance Issues
International Business Practices
- Cultural and Economic Considerations
- Trade and Tariff Implications
Strategic Alliances
- Partnerships and Joint Ventures
- Cross-Border Collaboration Opportunities

Business Model Innovation

Innovation Strategies
- New Business Models
- Disruptive Technologies
Value Proposition Development
- Unique Selling Points
- Customer Value Creation
Business Model Evaluation
- Model Validation and Testing
- Implementation and Scaling

Blue Ocean vs. Red Ocean Strategies

Blue Ocean Strategy
- Market Creation and Innovation
- Value Innovation and Differentiation
Red Ocean Strategy
- Competitive Positioning
- Market Share and Competitive Advantage
Strategic Comparison
- Strategic Advantages and Disadvantages
- Application to Market Segments

Competitive Landscape

Market Share Analysis
Competitive Benchmarking
Strategic Initiatives
Key Developments
- Product Launches
- Partnerships & Collaborations
- Acquisitions & Mergers

Company Profiles

Novartis AG
2seventy Bio Inc.
Anterogen Co., Ltd.
Johnson & Johnson Services, Inc
Astellas Pharma Inc.
M Aurion Biotech
EDIPOST
Atara Biotherapeutics
JCR Pharmaceuticals Co., Ltd.
S. BIOMEDICS
Holostem Terapie Avanzate S.r.l
Bristol-Myers Squibb Company
JW Therapeutics
Nkarta, Inc.
Gilead Sciences, Inc.

Market Trends and Insights

Technological Advancements
Regulatory Landscape
Market Drivers and Barriers
Future Outlook

Market Forecast

Market Size and Growth Projections
Revenue Forecast by Segment
- By Therapy Type
- By Therapeutic Area
- By Region
Competitive Forecast

Conclusion

Summary of Key Findings
Strategic Recommendations

Appendices

Glossary of Terms
Methodology
Data Sources
List of Abbreviations
Contact Information

Insight Code: 5210
No. of Pages: 150+
Format: PDF/PPT/Excel
Published: August 2024
Report Covered: [Revenue + Volume]
Historical Year: 2021-2022
Base Year: 2023
Estimated Years: 2024-2033

Proceed To Buy

Global Deep Dive Analysis

USD 5400

Single Region (NA,EU,APAC,LA,MEA)

USD 3800

Databook

USD 2100

Competitive Intelligence